This is unpublished

Kimberly L
Katz
MD

she/her/hers
Faculty
Pinned
Academic
Acting Instructor, Department of Dermatology
Sites of Practice
UW Medical Center – Roosevelt Dermatology Center
Eastside Specialty Center

APPOINTMENTS

UW Medical Center – Roosevelt Dermatology Center 

206.598.4067
Schedule Online

4225 Roosevelt Way NE, Floor 4
Seattle, WA 98105

 

Eastside Specialty Center

425.646.7777
Schedule Online

3100 Northup Way
Bellevue, WA 98004

 

BIOGRAPHY

Kimberly L. Katz, MD, FAAD is a board-certified dermatologist and full-time faculty member in the UW Department of Dermatology.  She currently practices at the UW Medical Center–Roosevelt Dermatology Center and the Eastside Specialty Center. In addition to her outpatient practice, Dr. Katz is one of the dermatology faculty members who teaches trainees on the inpatient dermatology consultation service.

Originally from New Jersey, Dr. Katz completed her dermatology residency at the Medical College of Wisconsin. She also completed a postdoctoral fellowship focused on psoriasis and psoriatic disease under the mentorship of Kenneth B. Gordon MD. 

She strives to be compassionate and accessible to patients, treating them as she would friends and family. Dr. Katz specializes in all aspects of medical dermatology including diagnosis, work up, and treatment of skin cancer and inflammatory skin conditions.

EDUCATION & TRAINING

Residency, Dermatology, Medical College of Wisconsin Affiliated Hospitals (2021-2024)

Research Fellow (Post-Doctoral), Dermatology, Medical College of Wisconsin (2019-2021)

Medicine Intern, Internal Medicine, Westchester Medical Center, Valhalla, NY (2018-2019) 

MD, New York Medical College (2014-2018)

Postbaccalaureate, Pre-medicine, Columbia University (2008-2010)

BA, Cum Laude, Latin American Studies, Barnard College, Columbia University (2004-2008) 

HONORS

Alpha Omega Alpha (AOA) (2024)

New York Medical College Exemplary Professionalism Recognition, Foundations of Clinical Medicine II (2016) 

Columbia University Clara M. Schiffrin Memorial Spanish Prize (2007)

SELECTED PUBLICATIONS

 

Trinidad J, Gabel CK, Han JJ, Bonomo L, Cartron A, Chand S, Coburn W, Daveluy S, Davis M, DeNiro KL, Guggina LM, Hennessy K, Hoffman M, Katz K, Keller JJ, Kim SJ, Konda S, Lake E, Lincoln FN, Lo JA, Markova A, Marvin EK, Micheletti RG, Newman S, Nutan FNU, Nguyen CV, Pahalyants V, Patel J, Rahnama-Moghadam S, Rambhatla PV, Riegert M, Reingold RE, Robinson DB, Rrapi R, Sartori-Valinotti JC, Seminario-Vidal L, Sharif-Sidi Z, Smogorzewski J, Spaccarelli N, Stewart JR, Tuttle SD, Ulrich MN, Wanat KA, Di Xia F, Kaffenberger B, Kroshinsky D. Telemedicine and dermatology hospital consultations during the COVID-19 pandemic: a multi-centre observational study on resource utilization and conversion to in-person consultations during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2022 May;36(5):e323- e325. doi: 10.1111/jdv.17898. Epub 2022 Jan 20. PMID: 34932237.

Creadore A, Desai S, Alloo A, Dewan AK, Bakhtiar M, Cruz-Diaz C, Femia A, Fox L, Katz KL, Micheletti R, Nelson CA. Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US. JAMA dermatology. 2022 Feb 1;158(2):176-83.

Noe MH, Wan MT, Mostaghimi A, Gelfand JM; Pustular Psoriasis in the US Research Group; Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Kirby JS, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. JAMA Dermatol. 2022 Jan 1;158(1):73-78. doi: 10.1001/jamadermatol.2021.4640. PMID: 34878491; PMCID: PMC8655659.

Katz K, Katsnelson J, Gottlieb, A. Health insurance status as a predictor of default to follow-up care in psoriasis patients. Journal of the American Academy of Dermatology 2019;81:AB69.